Weight-loss drug Mounjaro is poised for NHS rollout in England come March, with stories of transformative experiences from users like Alix Harvey and Jane Graham. Harvey, who lost a significant amount of weight, highlights the drug’s life-changing effects, while Graham expresses concern over eligibility and potential health risks. Both underscore the need for supportive measures alongside the medication to ensure lasting weight management. The rollout has raised questions about access and the NHS’s capacity to manage demand amidst ongoing health concerns.